Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02501915
Other study ID # 26582214.4.0000.5289
Secondary ID
Status Completed
Phase Phase 1
First received February 12, 2014
Last updated July 17, 2015
Start date February 2014
Est. completion date January 2015

Study information

Verified date July 2015
Source Universidade Estadual de Goiás
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The Kinesio Taping (KT ) method was developed more than thirty years ago in order to cause sensory effects through the epidermis and dermis, generating a variety of physiological effects in other systems. Clinical effects are well known levels in muscle, neurological system, injuries, inflammation, edema, among other physiological effects are thus largely in the theoretical framework. Objectives: The aim of this study is to evaluate the Electromyographic (EMG), Electroencephalographic (EEG), muscle temperature and flexibility effects with the Rectus Femoral muscle KT application. Methods: This is a pilot study with six subjects in which they were divided into two groups, A and B. Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the non-dominant limb and the dominant limb was used as control group. The first application was conducted at 0% and the second with 75 to 100% tension. Evaluations were performed before the first application, immediately and 24 hours later. After this last evaluation, was withdrawn taping, evaluated without taping, reapplied 75 to 100 % of rated voltage and in sequence. The sixth last review was conducted 24 hours after this last application. Before every application a specific vibration was performed on the patellar tendon in order to trigger a neurophysiological imbalance rectus femoral.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date January 2015
Est. primary completion date December 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria:

- Individuals who have authorized the evaluation procedure and through the Term Informed Consent;

- Individuals male and female of any race, duly enrolled in some college course of Universidade Salgado de Oliveira aged between 18-50 years old;

- Healthy subjects without disorders of locomotion without injury history the last 6 months in the lower limbs.

Exclusion Criteria:

- They are considered unfit for research individuals who do not meet the requirements listed above ;

- Individuals who have higher body mass index (BMI ) to 24.99, as the concentrated presence of fat on muscles can limit the effect of bracing;

- Individuals with musculoskeletal disorders and referring pain. Since there report that the pain and dysfunction of movement restricted range of motion and function muscular18 ;

- Individuals who possess too much on the thigh in which prevent proper attachment of bracing and the EMG electrode , or who refuse to perform the trichotomy .

- they show taping allergy ( an allergy test by putting a small bandage on the skin will be held and observed for 24 hours ) ;

- Patients with any contraindication how physical activity according to the guideline of the American College of Sports Medicine (ACSM , 1995), nerve root involvement, cardiorespiratory conditions and pregnancy .

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Device:
Kinesio Taping
Group A received the application of KT from muscle Origin to Insertion and group B Insertion to Origin, with both groups taped the nondominant limb and the dominant limb was used as control group. Diferent tensions will be applied with the tape to see its possible different affect in the outcomes.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Universidade Estadual de Goiás University of Brasilia

Outcome

Type Measure Description Time frame Safety issue
Other Muscle Stregth Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The strength will be measure by a Hand Hold Dynamometer (Kg/F) during an maximum isometric voluntary contraction. The outcome will be evaluated 24 hours after the intervention Yes
Other Local Temperture Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The temperature will be measure using Thermography (Degrees Celsius) before the KT applications, and 24 hs after staying with the KT applied to the skin. The outcome will be evaluated 24 hours after the intervention Yes
Primary Muscle Activity Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletromiography/ EMG (mV) will be measure during an maximum isometric voluntary contraction. The outcome will be evaluated 24 hours after the intervention Yes
Secondary Neurologic Activity Group A (n= 15) received the application of KT from muscle (Rectus femoral) Origin to Insertion, Group B (n= 15) from insertion to origin at the non dominant limb, and the dominant limb will be used as control group. The Eletroencephalography - EEG (Hz) will be measure during an maximum isometric voluntary contraction. Will be analyzed 8 channels related with the motor activity located between the frontal and the central lobe. The outcome will be evaluated 24 hours after the intervention Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06284954 - A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis Phase 2
Completed NCT06300983 - Effectiveness of a Psychoeducational Intervention on Myositis Patients' Quality of Life and Well-Being N/A
Recruiting NCT05832034 - Add-on Intravenous Immunoglobulins in Early Myositis Phase 2
Recruiting NCT05979441 - A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy Phase 3
Active, not recruiting NCT02468895 - MYOPROSP - a Prospective Cohort Study in Myositis
Recruiting NCT01501019 - Exercise in Sjogren, Myositis and Takayasu's Arteritis N/A
Recruiting NCT05523167 - A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. Phase 2/Phase 3
Completed NCT03414086 - Predictor of Clinical Response to Acthar in Myositis
Not yet recruiting NCT01702870 - Diagnostic Accuracy of MR in Myositis N/A
Terminated NCT03937856 - Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases N/A
Completed NCT03440034 - Study of Pioglitazone in Sporadic Inclusion Body Myositis Phase 1
Recruiting NCT05895786 - A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Phase 3
Completed NCT00001331 - Genetic and Family Studies of Inherited Muscle Diseases N/A
Terminated NCT04309227 - Comparison of Training Load With/Out Blood Flow Restriction Training in Rheumatoid Populations N/A
Completed NCT03059394 - Validation of Rehab Assessments in Myositis Patients N/A
Completed NCT00106184 - Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) Phase 2
Recruiting NCT04367350 - Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
Completed NCT01734369 - Environmental Risk Factors for Myositis in Military Personnel
Recruiting NCT02450396 - Pregnancy and Medically Assisted Conception in Rare Diseases
Recruiting NCT03912428 - Novel PET Radioligands as Inflammatory Biomarkers in Rheumatoid Arthritis and Myositis Phase 1